: Currently generating approximately ₹250 crore ($30M USD) in revenue, with a target of ₹1,000 crore ($120M USD) within three years. 2. Financial Health & Funding
: If you are seeing "ZENO" on US OTC markets, it likely refers to Zenosense, Inc. , a speculative "shell company" with zero revenue and a "Hold" consensus. is zeno stock a good buy
The company has successfully secured significant capital to fuel its expansion. : Currently generating approximately ₹250 crore ($30M USD)
: It bypasses supply chain bottlenecks by sourcing directly from manufacturers, allowing for competitive pricing of generic drugs. , a speculative "shell company" with zero revenue
Zeno Health is a Mumbai-based healthtech startup focused on making generic medicines accessible. : Private (Series C stage).
Zeno Health operates an that serves over 2.5 million consumers. Network : 180 physical stores and 200 micro-franchises.
: Zenotech Laboratories (ZENOTECH) is a public company in India, but it is a separate entity. Deep Paper: Analyzing Zeno Health for Investment 1. Business Model & Growth Trajectory